Breaking

‘Irrelevant’: Senators push back against Vought’s call for more partisan spending process
Biden-era policy indirectly paying for unaccompanied minors’ abortions rescinded by Trump DOJ
Unearthed chat sheds light on cozy ties between judges, climate activists, raising ethical concerns
Not ‘honest’ news organizations: White House defends yanking $9B ‘worth of crap’ in rescissions package
Johnson demands NARA turn over records related to Biden’s mental ‘decline’ amid Senate probe of ‘cover-up’
PETA applauds GOP lawmakers’ demand to halt NIH funding for ‘cruel’ overseas animal testing
State Department says US ‘unequivocally condemns’ Israeli airstrike in Syria, calls for ‘dialogue’
Senators push back against Vought’s call for more partisan spending process

Business
World
Investing
Politics
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Pacgold

CuFe Limited

Completion of PV Solar Cell Recycling Acquisition

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (617)
- Investing (2,204)
- Politics (2,709)
- World (2,534)

Disclaimer: ventureblessing.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 ventureblessing.com | All Rights Reserved

Top

Business
World
Investing
Politics

Type above and press Enter to search. Press Esc to cancel.